Short description
Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.
Description
Horizon Therapeutics operates as a biopharmaceutical company. It focuses on the development of prescription drugs for mild to moderate pain relief and arthritis. The company's product candidates include HZT-501, a proprietary fixed-dose combination formulation of NSAID and ibuprofen; and HZT-602, a combination oral drug product consisting of naproxen and famotidine.
Horizon Therapeutics is based in Northbrook, Illinois, and was founded in 2005.
Last funding
Cannot Access
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Northbrook, Illinois, United States, North America
Founded on
January 1, 2005
Exited on
August 5, 2011
Went public on
August 5, 2011
Delisted on
October 6, 2023
Stock symbol
HZNP
Non-profit?
No
Acquired?
No
Employees count
1001-5000
Revenue range
$1230 - 4560
Sign in for full access
Investors
Nopepepe, Noaccess, Noway Youcantaccess, No Way, Nopepepe, Absolutely Noaccess, Noway Youcantaccess, Cannot Access, Blurry Noaccess, Uh Ohhhh
Sign in for full access
Founders
George F. Tidmarsh